In our work, combinatorial treatment with oncolytic adenovirus and anti‐PD‐1 monotherapy markedly reduced the tumor growth and increased the tumor associated CD8/Treg ratio, promoting the ICB sensitivity in a CRC mouse model. This evidence concerns the gene CD8A and neoplasm.